Mitchell Sinkler & Starr’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,957
Closed -$319K 148
2025
Q1
$319K Buy
3,957
+92
+2% +$7.91K 0.09% 130
2024
Q4
$302K Hold
3,865
0.08% 136
2024
Q3
$363K Hold
3,865
0.09% 126
2024
Q2
$313K Buy
3,865
+727
+23% +$59.3K 0.08% 122
2024
Q1
$285K Sell
3,138
-4,223
-57% -$351K 0.07% 138
2023
Q4
$569K Buy
7,361
+2,716
+58% +$190K 0.1% 125
2023
Q3
$316K Buy
4,645
+1,507
+48% +$110K 0.1% 98
2023
Q2
$255K Hold
3,138
0.07% 129
2023
Q1
$257K Buy
+3,138
New +$224K 0.08% 127

Other funds holding GEHC

Mitchell Sinkler & Starr's GEHC Position: Q2 2025 in Review

Mitchell Sinkler & Starr sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 3,957 shares — an estimated $319K sold.

Mitchell Sinkler & Starr first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $569K in Q4 2023. 1,311 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • Mitchell Sinkler & Starr reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • Mitchell Sinkler & Starr sold 3,957 GE HealthCare shares in Q2 2025, an estimated $319K.
  • Mitchell Sinkler & Starr first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Mitchell Sinkler & Starr's GE HealthCare position peaked at $569K in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2025, filed 25 Jul 2025.